LOCUS       NP_001393649            3401 aa            linear   PRI 22-OCT-2023
DEFINITION  breast cancer type 2 susceptibility protein isoform 2 [Homo
            sapiens].
ACCESSION   NP_001393649
VERSION     NP_001393649.1
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    REFSEQ: accession NM_001406720.1
REFERENCE   1  (residues 1 to 3401)
  AUTHORS   Rein HL and Bernstein KA.
  TITLE     Finding significance: New perspectives in variant classification of
            the RAD51 regulators, BRCA2 and beyond
  JOURNAL   DNA Repair (Amst) 130, 103563 (2023)
   PUBMED   37651978
  REMARK    GeneRIF: Finding significance: New perspectives in variant
            classification of the RAD51 regulators, BRCA2 and beyond. Review
            article
REFERENCE   2  (residues 1 to 3401)
  AUTHORS   Mohammed Ali SH, Abid Mohammed KI, Ali WM, Al-Fakhar SA, Al-Alwany
            SHM and Mousa JM.
  TITLE     Immunohistochemical Detection of the Expressed BRCA1 and BRCA2
            Proteins in Microenvironment of Malignant Breast Cancerous Tissues
            Infected with Human Mammary Tumor Virus
  JOURNAL   Asian Pac J Cancer Prev 24 (9), 3261-3267 (2023)
   PUBMED   37774080
  REMARK    GeneRIF: Immunohistochemical Detection of the Expressed BRCA1 and
            BRCA2 Proteins in Microenvironment of Malignant Breast Cancerous
            Tissues Infected with Human Mammary Tumor Virus. Publication Status:
            Online-Only
REFERENCE   3  (residues 1 to 3401)
  AUTHORS   Wilcox N, Dumont M, Gonzalez-Neira A, Carvalho S, Joly Beauparlant
            C, Crotti M, Luccarini C, Soucy P, Dubois S, Nunez-Torres R, Pita G,
            Gardner EJ, Dennis J, Alonso MR, Alvarez N, Baynes C,
            Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK,
            Castelao JE, Chang-Claude J, Cornelissen S, Dork T, Engel C,
            Gago-Dominguez M, Guenel P, Hadjisavvas A, Hahnen E, Hartman M,
            Herraez B, Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M,
            Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der
            Kolk LE, Wahlstrom C, Wang Q, Perry JRB, Benitez J, Schmidt MK,
            Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P,
            Easton DF and Simard J.
  CONSRTM   SGBCC Investigators
  TITLE     Exome sequencing identifies breast cancer susceptibility genes and
            defines the contribution of coding variants to breast cancer risk
  JOURNAL   Nat Genet 55 (9), 1435-1439 (2023)
   PUBMED   37592023
  REMARK    GeneRIF: Exome sequencing identifies breast cancer susceptibility
            genes and defines the contribution of coding variants to breast
            cancer risk. Erratum:[Nat Genet. 2023 Sep 26;:. PMID: 37752376]
REFERENCE   4  (residues 1 to 3401)
  AUTHORS   Setton J, Hadi K, Choo ZN, Kuchin KS, Tian H, Da Cruz Paula A,
            Rosiene J, Selenica P, Behr J, Yao X, Deshpande A, Sigouros M,
            Manohar J, Nauseef JT, Mosquera JM, Elemento O, Weigelt B, Riaz N,
            Reis-Filho JS, Powell SN and Imielinski M.
  TITLE     Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers
  JOURNAL   Nature 621 (7977), 129-137 (2023)
   PUBMED   37587346
  REMARK    GeneRIF: Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers.
REFERENCE   5  (residues 1 to 3401)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach
            R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat Genet 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (residues 1 to 3401)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc Natl Acad Sci U S A 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (residues 1 to 3401)
  AUTHORS   Mehta,P.A. and Ebens,C.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301575
REFERENCE   8  (residues 1 to 3401)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   9  (residues 1 to 3401)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301425
REFERENCE   10  (residues 1 to 3401)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: SRR14038194.4125333.1 [ECO:0000332]
            RNAseq introns :: single sample supports all introns SAMEA1968968,
            SAMEA2149876 [ECO:0000348]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9 and AL137247.14.
            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The largest exon in both genes is exon
            11, which harbors the most important and frequent mutations in
            breast cancer patients. The BRCA2 gene was found on chromosome
            13q12.3 in human. The BRCA2 protein contains several copies of a 70
            aa motif called the BRC motif, and these motifs mediate binding to
            the RAD51 recombinase which functions in DNA repair. BRCA2 is
            considered a tumor suppressor gene, as tumors with BRCA2 mutations
            generally exhibit loss of heterozygosity (LOH) of the wild-type
            allele. [provided by RefSeq, May 2020].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..3401
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     Protein         1..3401
                     /product="breast cancer type 2 susceptibility protein
                     isoform 2"
                     /note="BRCA1/BRCA2-containing complex, subunit 2; breast
                     cancer type 2 susceptibility protein; DNA repair-associated
                     BRCA2; breast cancer 2 tumor suppressor; breast and ovarian
                     cancer susceptibility gene, early onset; Fanconi anemia
                     group D1 protein; breast and ovarian cancer susceptibility
                     protein 2; breast cancer 2, early onset; mutant BRCA2;
                     mutant DNA repair-associated protein 2"
                     /calculated_mol_wt="382156"
     Region          1..40
                     /region_name="Interaction with PALB2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          37..68
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            70
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          358..381
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            445
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            492
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          639..1000
                     /region_name="Interaction with NPM1.
                     /evidence=ECO:0000269|PubMed:21084279"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            755
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:17525332; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1002..1036
                     /region_name="BRCA2 1"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1003..2082
                     /region_name="Interaction with RAD51.
                     /evidence=ECO:0000250|UniProtKB:P97929"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1005..1033
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1216..1243
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1338..1781
                     /region_name="Interaction with POLH.
                     /evidence=ECO:0000269|PubMed:24485656"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1410..1595
                     /region_name="Required for stimulation of POLH DNA
                     polymerization activity"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1424..1452
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1522..1548
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1667..1695
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            1970
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1974..2002
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2035
                     /site_type="phosphorylation"
                     /note="Phosphothreonine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2051..2085
                     /region_name="BRCA2 8"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2055..2082
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2095
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2270..2337
                     /region_name="Interaction with HSF2BP.
                     /evidence=ECO:0000269|PubMed:31242413"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2350..2545
                     /region_name="Interaction with FANCD2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2430..2450
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2481..2832
                     /region_name="Interaction with SEM1.
                     /evidence=ECO:0000269|PubMed:10373512,
                     ECO:0000269|PubMed:16205630"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2481..2667
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:430446"
     Region          2670..2796
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:430410"
     Region          2682..2698
                     /region_name="Nuclear export signal, masked by interaction
                     with SEM1. /evidence=ECO:0000269|PubMed:24013206"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            order(2690..2692,2718..2721,2723,2729..2731,2733,2749,
                     2757..2759,2775..2777)
                     /site_type="active"
                     /note="generic binding surface I [active]"
                     /db_xref="CDD:239939"
     Site            order(2725,2736,2739,2744,2747,2750,2782..2785,2787..2788,
                     2791..2792)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239939"
     Region          2804..3037
                     /region_name="BRCA2DBD_OB2"
                     /note="A subfamily of OB folds corresponding to the second
                     OB fold (OB2) of the 800-amino acid C-terminal ssDNA
                     binding domain (DBD) of BRCA2 (breast cancer susceptibility
                     gene 2) protein, called BRCA2DBD. BRCA2 participates in
                     homologous recombination-mediated...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(2808..2809,2811..2814,2816)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239940"
     Site            order(2826..2827,2829,2841,2846,2973,3033,3035..3037)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Region          3035..3169
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:430411"
     Site            order(3056,3102,3104,3106,3130)
                     /site_type="active"
                     /note="generic binding surface II [active]"
                     /db_xref="CDD:239941"
     Site            order(3069..3071,3111,3122,3124..3125)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     Site            3274
                     /site_type="phosphorylation"
                     /note="Phosphoserine, by CDK1 and CDK2.
                     /evidence=ECO:0000269|PubMed:15800615; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3302
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3370
                     /site_type="phosphorylation"
                     /note="Phosphothreonine, by CHEK1 and CHEK2.
                     /evidence=ECO:0000269|PubMed:18317453; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          3376..3401
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     CDS             1..3401
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /coded_by="NM_001406720.1:200..10405"
                     /note="isoform 2 is encoded by transcript variant 2"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
ORIGIN
        1 mpigskerpt ffeifktrcn kadlgpisln wfeelsseap pynsepaees ehknnnyepn
       61 lfktpqrkps ynqlastpii fkeqgltlpl yqspvkeldk fkldlgrnvp nsrhkslrtv
      121 ktkmdqaddv scpllnscls espvvlqcth vtpqrdksvv cgslfhtpkf vkgrqtpkhi
      181 seslgaevdp dmswssslat pptlsstvli vrneeasetv fphdttanvk syfsnhdesl
      241 kkndrfiasv tdsentnqre aashgfgkts gnsfkvnsck dhigksmpnv ledevyetvv
      301 dtseedsfsl cfskcrtknl qkvrtsktrk kifheanade ceksknqvke kysfvsevep
      361 ndtdpldsnv anqkpfesgs dkiskevvps lacewsqltl sglngaqmek ipllhisscd
      421 qnisekdlld tenkrkkdfl tsenslpris slpksekpln eetvvnkrde eqhleshtdc
      481 ilavkqaisg tspvassfqg ikksifrire spketfnasf sghmtdpnfk keteasesgl
      541 eihtvcsqke dslcpnlidn gswpatttqn svalknagli stlkkktnkf iyaihdetsy
      601 kgkkipkdqk selincsaqf eanafeaplt fanadsgllh ssvkrscsqn dseeptlslt
      661 ssfgtilrkc srnetcsnnt visqdldyke akcnkeklql fitpeadsls clqegqcend
      721 pkskkvsdik eevlaaachp vqhskveysd tdfqsqksll ydhenastli ltptskdvls
      781 nlvmisrgke sykmsdklkg nnyesdvelt knipmeknqd vcalnenykn vellppekym
      841 rvaspsrkvq fnqntnlrvi qknqeettsi skitvnpdse elfsdnennf vfqvanernn
      901 lalgntkelh etdltcvnep ifknstmvly gdtgdkqatq vsikkdlvyv laeenknsvk
      961 qhikmtlgqd lksdislnid kipeknndym nkwagllgpi snhsfggsfr tasnkeikls
     1021 ehnikkskmf fkdieeqypt slacveivnt laldnqkkls kpqsintvsa hlqssvvvsd
     1081 cknshitpqm lfskqdfnsn hnltpsqkae itelstilee sgsqfeftqf rkpsyilqks
     1141 tfevpenqmt ilkttseecr dadlhvimna psigqvdssk qfegtveikr kfagllkndc
     1201 nksasgyltd enevgfrgfy sahgtklnvs tealqkavkl fsdienisee tsaevhpisl
     1261 ssskchdsvv smfkienhnd ktvseknnkc qlilqnniem ttgtfveeit enykrntene
     1321 dnkytaasrn shnlefdgsd sskndtvcih kdetdllftd qhniclklsg qfmkegntqi
     1381 kedlsdltfl evakaqeach gntsnkeqlt atkteqnikd fetsdtffqt asgknisvak
     1441 esfnkivnff dqkpeelhnf slnselhsdi rknkmdilsy eetdivkhki lkesvpvgtg
     1501 nqlvtfqgqp erdekikept llgfhtasgk kvkiakesld kvknlfdeke qgtseitsfs
     1561 hqwaktlkyr eackdlelac etieitaapk ckemqnslnn dknlvsietv vppkllsdnl
     1621 crqtenlkts ksiflkvkvh enveketaks patcytnqsp ysviensala fytscsrkts
     1681 vsqtslleak kwlregifdg qperintady vgnylyenns nstiaendkn hlsekqdtyl
     1741 snssmsnsys yhsdevynds gylsknklds giepvlknve dqkntsfskv isnvkdanay
     1801 pqtvnedicv eelvtssspc knknaaikls isnsnnfevg ppafriasgk ivcvshetik
     1861 kvkdiftdsf skvikennen kskicqtkim agcyealdds edilhnsldn decsthshkv
     1921 fadiqseeil qhnqnmsgle kvskispcdv sletsdickc sigklhksvs santcgifst
     1981 asgksvqvsd aslqnarqvf seiedstkqv fskvlfksne hsdqltreen tairtpehli
     2041 sqkgfsynvv nssafsgfst asgkqvsile sslhkvkgvl eefdlirteh slhysptsrq
     2101 nvskilprvd krnpehcvns emektcskef klsnnlnveg gssennhsik vspylsqfqq
     2161 dkqqlvlgtk vslvenihvl gkeqaspknv kmeigktetf sdvpvktnie vcstyskdse
     2221 nyfeteavei akafmeddel tdsklpshat hslftcpene emvlsnsrig krrgeplilv
     2281 gepsikrnll nefdriienq ekslkaskst pdgtikdrrl fmhhvslepi tcvpfrttke
     2341 rqeiqnpnft apgqeflsks hlyehltlek sssnlavsgh pfyqvsatrn ekmrhlittg
     2401 rptkvfvppf ktkshfhrve qcvrninlee nrqkqnidgh gsddsknkin dneihqfnkn
     2461 nsnqavavtf tkceeepldl itslqnardi qdmrikkkqr qrvfpqpgsl ylaktstlpr
     2521 islkaavggq vpsacshkql ytygvskhci kinsknaesf qfhtedyfgk eslwtgkgiq
     2581 ladggwlips ndgkagkeef yralcdtpgv dpklisriwv ynhyrwiiwk laamecafpk
     2641 efanrclspe rvllqlkyry dteidrsrrs aikkimerdd taaktlvlcv sdiislsani
     2701 setssnktss adtqkvaiie ltdgwyavka qldppllavl kngrltvgqk iilhgaelvg
     2761 spdactplea peslmlkisa nstrparwyt klgffpdprp fplplsslfs dggnvgcvdv
     2821 iiqraypiqw mektssglyi frnereeeke aakyveaqqk rlealftkiq eefeeheent
     2881 tkpylpsral trqqvralqd gaelyeavkn aadpaylegy fseeqlraln nhrqmlndkk
     2941 qaqiqleirk amesaeqkeq glsrdvttvw klrivsyskk ekdsegkryr iyhlatsksk
     3001 skseraniql aatkktqyqq lpvsdeilfq iyqpreplhf skfldpdfqp scsevdligf
     3061 vvsvvkktgl apfvylsdec ynllaikfwi dlnediikph mliaasnlqw rpesksgllt
     3121 lfagdfsvfs aspkeghfqe tfnkmkntve nidilcneae nklmhilhan dpkwstptkd
     3181 ctsgpytaqi ipgtgnkllm sspnceiyyq splslcmakr ksvstpvsaq mtsksckgek
     3241 eiddqknckk rraldflsrl plpppvspic tfvspaaqka fqpprscgtk yetpikkkel
     3301 nspqmtpfkk fneisllesn siadeelali ntqallsgst gekqfisvse strtaptsse
     3361 dylrlkrrct tslikeqess qasteecekn kqdtittkky i
//
LOCUS       NP_001393650            1774 aa            linear   PRI 22-OCT-2023
DEFINITION  breast cancer type 2 susceptibility protein isoform 4 [Homo
            sapiens].
ACCESSION   NP_001393650
VERSION     NP_001393650.1
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    REFSEQ: accession NM_001406721.1
REFERENCE   1  (residues 1 to 1774)
  AUTHORS   Rein HL and Bernstein KA.
  TITLE     Finding significance: New perspectives in variant classification of
            the RAD51 regulators, BRCA2 and beyond
  JOURNAL   DNA Repair (Amst) 130, 103563 (2023)
   PUBMED   37651978
  REMARK    GeneRIF: Finding significance: New perspectives in variant
            classification of the RAD51 regulators, BRCA2 and beyond. Review
            article
REFERENCE   2  (residues 1 to 1774)
  AUTHORS   Mohammed Ali SH, Abid Mohammed KI, Ali WM, Al-Fakhar SA, Al-Alwany
            SHM and Mousa JM.
  TITLE     Immunohistochemical Detection of the Expressed BRCA1 and BRCA2
            Proteins in Microenvironment of Malignant Breast Cancerous Tissues
            Infected with Human Mammary Tumor Virus
  JOURNAL   Asian Pac J Cancer Prev 24 (9), 3261-3267 (2023)
   PUBMED   37774080
  REMARK    GeneRIF: Immunohistochemical Detection of the Expressed BRCA1 and
            BRCA2 Proteins in Microenvironment of Malignant Breast Cancerous
            Tissues Infected with Human Mammary Tumor Virus. Publication Status:
            Online-Only
REFERENCE   3  (residues 1 to 1774)
  AUTHORS   Wilcox N, Dumont M, Gonzalez-Neira A, Carvalho S, Joly Beauparlant
            C, Crotti M, Luccarini C, Soucy P, Dubois S, Nunez-Torres R, Pita G,
            Gardner EJ, Dennis J, Alonso MR, Alvarez N, Baynes C,
            Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK,
            Castelao JE, Chang-Claude J, Cornelissen S, Dork T, Engel C,
            Gago-Dominguez M, Guenel P, Hadjisavvas A, Hahnen E, Hartman M,
            Herraez B, Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M,
            Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der
            Kolk LE, Wahlstrom C, Wang Q, Perry JRB, Benitez J, Schmidt MK,
            Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P,
            Easton DF and Simard J.
  CONSRTM   SGBCC Investigators
  TITLE     Exome sequencing identifies breast cancer susceptibility genes and
            defines the contribution of coding variants to breast cancer risk
  JOURNAL   Nat Genet 55 (9), 1435-1439 (2023)
   PUBMED   37592023
  REMARK    GeneRIF: Exome sequencing identifies breast cancer susceptibility
            genes and defines the contribution of coding variants to breast
            cancer risk. Erratum:[Nat Genet. 2023 Sep 26;:. PMID: 37752376]
REFERENCE   4  (residues 1 to 1774)
  AUTHORS   Setton J, Hadi K, Choo ZN, Kuchin KS, Tian H, Da Cruz Paula A,
            Rosiene J, Selenica P, Behr J, Yao X, Deshpande A, Sigouros M,
            Manohar J, Nauseef JT, Mosquera JM, Elemento O, Weigelt B, Riaz N,
            Reis-Filho JS, Powell SN and Imielinski M.
  TITLE     Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers
  JOURNAL   Nature 621 (7977), 129-137 (2023)
   PUBMED   37587346
  REMARK    GeneRIF: Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers.
REFERENCE   5  (residues 1 to 1774)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach
            R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat Genet 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (residues 1 to 1774)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc Natl Acad Sci U S A 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (residues 1 to 1774)
  AUTHORS   Mehta,P.A. and Ebens,C.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301575
REFERENCE   8  (residues 1 to 1774)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   9  (residues 1 to 1774)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301425
REFERENCE   10  (residues 1 to 1774)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: SRR14038194.2834890.1,
            SRR18074967.568273.1 [ECO:0000332]
            RNAseq introns :: single sample supports all introns SAMEA2154529,
            SAMEA2161674 [ECO:0000348]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9 and AL137247.14.
            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The largest exon in both genes is exon
            11, which harbors the most important and frequent mutations in
            breast cancer patients. The BRCA2 gene was found on chromosome
            13q12.3 in human. The BRCA2 protein contains several copies of a 70
            aa motif called the BRC motif, and these motifs mediate binding to
            the RAD51 recombinase which functions in DNA repair. BRCA2 is
            considered a tumor suppressor gene, as tumors with BRCA2 mutations
            generally exhibit loss of heterozygosity (LOH) of the wild-type
            allele. [provided by RefSeq, May 2020].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..1774
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     Protein         1..1774
                     /product="breast cancer type 2 susceptibility protein
                     isoform 4"
                     /note="BRCA1/BRCA2-containing complex, subunit 2; breast
                     cancer type 2 susceptibility protein; DNA repair-associated
                     BRCA2; breast cancer 2 tumor suppressor; breast and ovarian
                     cancer susceptibility gene, early onset; Fanconi anemia
                     group D1 protein; breast and ovarian cancer susceptibility
                     protein 2; breast cancer 2, early onset; mutant BRCA2;
                     mutant DNA repair-associated protein 2"
                     /calculated_mol_wt="199894"
     Region          1..40
                     /region_name="Interaction with PALB2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          37..68
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            70
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          358..381
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            445
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            492
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          837..1023
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:430446"
     Region          1026..1152
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:430410"
     Site            order(1046..1048,1074..1077,1079,1085..1087,1089,1105,
                     1113..1115,1131..1133)
                     /site_type="active"
                     /note="generic binding surface I [active]"
                     /db_xref="CDD:239939"
     Site            order(1081,1092,1095,1100,1103,1106,1138..1141,1143..1144,
                     1147..1148)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239939"
     Region          1160..1410
                     /region_name="BRCA2DBD_OB2"
                     /note="A subfamily of OB folds corresponding to the second
                     OB fold (OB2) of the 800-amino acid C-terminal ssDNA
                     binding domain (DBD) of BRCA2 (breast cancer susceptibility
                     gene 2) protein, called BRCA2DBD. BRCA2 participates in
                     homologous recombination-mediated...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(1164..1165,1167..1170,1172)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239940"
     Site            order(1182..1183,1185,1197,1202,1329,1406,1408..1410)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Site            order(1197,1327,1344,1346..1347,1382,1384)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239940"
     Region          1408..1542
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:430411"
     Site            order(1429,1475,1477,1479,1503)
                     /site_type="active"
                     /note="generic binding surface II [active]"
                     /db_xref="CDD:239941"
     Site            order(1442..1444,1484,1495,1497..1498)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     CDS             1..1774
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /coded_by="NM_001406721.1:200..5524"
                     /note="isoform 4 is encoded by transcript variant 4"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
ORIGIN
        1 mpigskerpt ffeifktrcn kadlgpisln wfeelsseap pynsepaees ehknnnyepn
       61 lfktpqrkps ynqlastpii fkeqgltlpl yqspvkeldk fkldlgrnvp nsrhkslrtv
      121 ktkmdqaddv scpllnscls espvvlqcth vtpqrdksvv cgslfhtpkf vkgrqtpkhi
      181 seslgaevdp dmswssslat pptlsstvli vrneeasetv fphdttanvk syfsnhdesl
      241 kkndrfiasv tdsentnqre aashgfgkts gnsfkvnsck dhigksmpnv ledevyetvv
      301 dtseedsfsl cfskcrtknl qkvrtsktrk kifheanade ceksknqvke kysfvsevep
      361 ndtdpldsnv anqkpfesgs dkiskevvps lacewsqltl sglngaqmek ipllhisscd
      421 qnisekdlld tenkrkkdfl tsenslpris slpksekpln eetvvnkrde eqhleshtdc
      481 ilavkqaisg tspvassfqg ikksifrire spketfnasf sghmtdpnfk keteasesgl
      541 eihtvcsqke dslcpnlidn gswpatttqn svalknagli stlkkktnkf iyaihdetsy
      601 kgkkipkdqk selincsaqf eanafeaplt fanadsgeps ikrnllnefd riienqeksl
      661 kaskstpdgt ikdrrlfmhh vslepitcvp frttkerqei qnpnftapgq eflskshlye
      721 hltleksssn lavsghpfyq vsatrnekmr hlittgrptk vfvppfktks hfhrveqcvr
      781 ninleenrqk qnidghgsdd sknkindnei hqfnknnsnq avavtftkce eepldlitsl
      841 qnardiqdmr ikkkqrqrvf pqpgslylak tstlprislk aavggqvpsa cshkqlytyg
      901 vskhcikins knaesfqfht edyfgkeslw tgkgiqladg gwlipsndgk agkeefyral
      961 cdtpgvdpkl isriwvynhy rwiiwklaam ecafpkefan rclspervll qlkyrydtei
     1021 drsrrsaikk imerddtaak tlvlcvsdii slsanisets snktssadtq kvaiieltdg
     1081 wyavkaqldp pllavlkngr ltvgqkiilh gaelvgspda ctpleapesl mlkisanstr
     1141 parwytklgf fpdprpfplp lsslfsdggn vgcvdviiqr aypiqwmekt ssglyifrne
     1201 reeekeaaky veaqqkrlea lftkiqeefe eheenttkpy lpsraltrqq vralqdgael
     1261 yeavknaadp aylegyfsee qlralnnhrq mlndkkqaqi qleirkames aeqkeqglsr
     1321 dvttvwklri vsyskkekds vilsiwrpss dlyslltegk ryriyhlats kskskseran
     1381 iqlaatkktq yqqlpvsdei lfqiyqprep lhfskfldpd fqpscsevdl igfvvsvvkk
     1441 tglapfvyls decynllaik fwidlnedii kphmliaasn lqwrpesksg lltlfagdfs
     1501 vfsaspkegh fqetfnkmkn tvenidilcn eaenklmhil handpkwstp tkdctsgpyt
     1561 aqiipgtgnk llmsspncei yyqsplslcm akrksvstpv saqmtsksck gekeiddqkn
     1621 ckkrraldfl srlplpppvs pictfvspaa qkafqpprsc gtkyetpikk kelnspqmtp
     1681 fkkfneisll esnsiadeel alintqalls gstgekqfis vsestrtapt ssedylrlkr
     1741 rcttslikeq essqasteec eknkqdtitt kkyi
//
LOCUS       NP_001393651            1279 aa            linear   PRI 22-OCT-2023
DEFINITION  breast cancer type 2 susceptibility protein isoform 5 [Homo
            sapiens].
ACCESSION   NP_001393651
VERSION     NP_001393651.1
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    REFSEQ: accession NM_001406722.1
REFERENCE   1  (residues 1 to 1279)
  AUTHORS   Rein HL and Bernstein KA.
  TITLE     Finding significance: New perspectives in variant classification of
            the RAD51 regulators, BRCA2 and beyond
  JOURNAL   DNA Repair (Amst) 130, 103563 (2023)
   PUBMED   37651978
  REMARK    GeneRIF: Finding significance: New perspectives in variant
            classification of the RAD51 regulators, BRCA2 and beyond. Review
            article
REFERENCE   2  (residues 1 to 1279)
  AUTHORS   Mohammed Ali SH, Abid Mohammed KI, Ali WM, Al-Fakhar SA, Al-Alwany
            SHM and Mousa JM.
  TITLE     Immunohistochemical Detection of the Expressed BRCA1 and BRCA2
            Proteins in Microenvironment of Malignant Breast Cancerous Tissues
            Infected with Human Mammary Tumor Virus
  JOURNAL   Asian Pac J Cancer Prev 24 (9), 3261-3267 (2023)
   PUBMED   37774080
  REMARK    GeneRIF: Immunohistochemical Detection of the Expressed BRCA1 and
            BRCA2 Proteins in Microenvironment of Malignant Breast Cancerous
            Tissues Infected with Human Mammary Tumor Virus. Publication Status:
            Online-Only
REFERENCE   3  (residues 1 to 1279)
  AUTHORS   Wilcox N, Dumont M, Gonzalez-Neira A, Carvalho S, Joly Beauparlant
            C, Crotti M, Luccarini C, Soucy P, Dubois S, Nunez-Torres R, Pita G,
            Gardner EJ, Dennis J, Alonso MR, Alvarez N, Baynes C,
            Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK,
            Castelao JE, Chang-Claude J, Cornelissen S, Dork T, Engel C,
            Gago-Dominguez M, Guenel P, Hadjisavvas A, Hahnen E, Hartman M,
            Herraez B, Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M,
            Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der
            Kolk LE, Wahlstrom C, Wang Q, Perry JRB, Benitez J, Schmidt MK,
            Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P,
            Easton DF and Simard J.
  CONSRTM   SGBCC Investigators
  TITLE     Exome sequencing identifies breast cancer susceptibility genes and
            defines the contribution of coding variants to breast cancer risk
  JOURNAL   Nat Genet 55 (9), 1435-1439 (2023)
   PUBMED   37592023
  REMARK    GeneRIF: Exome sequencing identifies breast cancer susceptibility
            genes and defines the contribution of coding variants to breast
            cancer risk. Erratum:[Nat Genet. 2023 Sep 26;:. PMID: 37752376]
REFERENCE   4  (residues 1 to 1279)
  AUTHORS   Setton J, Hadi K, Choo ZN, Kuchin KS, Tian H, Da Cruz Paula A,
            Rosiene J, Selenica P, Behr J, Yao X, Deshpande A, Sigouros M,
            Manohar J, Nauseef JT, Mosquera JM, Elemento O, Weigelt B, Riaz N,
            Reis-Filho JS, Powell SN and Imielinski M.
  TITLE     Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers
  JOURNAL   Nature 621 (7977), 129-137 (2023)
   PUBMED   37587346
  REMARK    GeneRIF: Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers.
REFERENCE   5  (residues 1 to 1279)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach
            R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat Genet 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (residues 1 to 1279)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc Natl Acad Sci U S A 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (residues 1 to 1279)
  AUTHORS   Mehta,P.A. and Ebens,C.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301575
REFERENCE   8  (residues 1 to 1279)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   9  (residues 1 to 1279)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301425
REFERENCE   10  (residues 1 to 1279)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: SRR14038192.3765894.1 [ECO:0000332]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9 and AL137247.14.
            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The largest exon in both genes is exon
            11, which harbors the most important and frequent mutations in
            breast cancer patients. The BRCA2 gene was found on chromosome
            13q12.3 in human. The BRCA2 protein contains several copies of a 70
            aa motif called the BRC motif, and these motifs mediate binding to
            the RAD51 recombinase which functions in DNA repair. BRCA2 is
            considered a tumor suppressor gene, as tumors with BRCA2 mutations
            generally exhibit loss of heterozygosity (LOH) of the wild-type
            allele. [provided by RefSeq, May 2020].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..1279
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     Protein         1..1279
                     /product="breast cancer type 2 susceptibility protein
                     isoform 5"
                     /note="BRCA1/BRCA2-containing complex, subunit 2; breast
                     cancer type 2 susceptibility protein; DNA repair-associated
                     BRCA2; breast cancer 2 tumor suppressor; breast and ovarian
                     cancer susceptibility gene, early onset; Fanconi anemia
                     group D1 protein; breast and ovarian cancer susceptibility
                     protein 2; breast cancer 2, early onset; mutant BRCA2;
                     mutant DNA repair-associated protein 2"
                     /calculated_mol_wt="144397"
     Region          342..528
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:430446"
     Region          531..657
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:430410"
     Site            order(551..553,579..582,584,590..592,594,610,618..620,
                     636..638)
                     /site_type="active"
                     /note="generic binding surface I [active]"
                     /db_xref="CDD:239939"
     Site            order(586,597,600,605,608,611,643..646,648..649,652..653)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239939"
     Region          665..915
                     /region_name="BRCA2DBD_OB2"
                     /note="A subfamily of OB folds corresponding to the second
                     OB fold (OB2) of the 800-amino acid C-terminal ssDNA
                     binding domain (DBD) of BRCA2 (breast cancer susceptibility
                     gene 2) protein, called BRCA2DBD. BRCA2 participates in
                     homologous recombination-mediated...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(669..670,672..675,677)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239940"
     Site            order(687..688,690,702,707,834,911,913..915)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Site            order(702,832,849,851..852,887,889)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239940"
     Region          913..1047
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:430411"
     Site            order(934,980,982,984,1008)
                     /site_type="active"
                     /note="generic binding surface II [active]"
                     /db_xref="CDD:239941"
     Site            order(947..949,989,1000,1002..1003)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     CDS             1..1279
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /coded_by="NM_001406722.1:463..4302"
                     /note="isoform 5 is encoded by transcript variant 5"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
ORIGIN
        1 mdqaddvscp llnsclsesp vvlqcthvtp qrdksvvcgs lfhtpkfvkg rqtpkhises
       61 lgaevdpdms wssslatppt lsstvlivrn eeasetvfph dttanvksyf snhdeslkkn
      121 drfiasvtds entnqreaas hgepsikrnl lnefdriien qekslkasks tpdgtikdrr
      181 lfmhhvslep itcvpfrttk erqeiqnpnf tapgqeflsk shlyehltle ksssnlavsg
      241 hpfyqvsatr nekmrhlitt grptkvfvpp fktkshfhrv eqcvrninle enrqkqnidg
      301 hgsddsknki ndneihqfnk nnsnqavavt ftkceeepld litslqnard iqdmrikkkq
      361 rqrvfpqpgs lylaktstlp rislkaavgg qvpsacshkq lytygvskhc ikinsknaes
      421 fqfhtedyfg keslwtgkgi qladggwlip sndgkagkee fyralcdtpg vdpklisriw
      481 vynhyrwiiw klaamecafp kefanrclsp ervllqlkyr ydteidrsrr saikkimerd
      541 dtaaktlvlc vsdiislsan isetssnkts sadtqkvaii eltdgwyavk aqldppllav
      601 lkngrltvgq kiilhgaelv gspdactple apeslmlkis anstrparwy tklgffpdpr
      661 pfplplsslf sdggnvgcvd viiqraypiq wmektssgly ifrnereeek eaakyveaqq
      721 krlealftki qeefeeheen ttkpylpsra ltrqqvralq dgaelyeavk naadpayleg
      781 yfseeqlral nnhrqmlndk kqaqiqleir kamesaeqke qglsrdvttv wklrivsysk
      841 kekdsvilsi wrpssdlysl ltegkryriy hlatsksksk seraniqlaa tkktqyqqlp
      901 vsdeilfqiy qpreplhfsk fldpdfqpsc sevdligfvv svvkktglap fvylsdecyn
      961 llaikfwidl nediikphml iaasnlqwrp esksglltlf agdfsvfsas pkeghfqetf
     1021 nkmkntveni dilcneaenk lmhilhandp kwstptkdct sgpytaqiip gtgnkllmss
     1081 pnceiyyqsp lslcmakrks vstpvsaqmt sksckgekei ddqknckkrr aldflsrlpl
     1141 pppvspictf vspaaqkafq pprscgtkye tpikkkelns pqmtpfkkfn eisllesnsi
     1201 adeelalint qallsgstge kqfisvsest rtaptssedy lrlkrrctts likeqessqa
     1261 steeceknkq dtittkkyi
//
LOCUS       NP_001393648            3386 aa            linear   PRI 22-OCT-2023
DEFINITION  breast cancer type 2 susceptibility protein isoform 3 [Homo
            sapiens].
ACCESSION   NP_001393648
VERSION     NP_001393648.1
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    REFSEQ: accession NM_001406719.1
REFERENCE   1  (residues 1 to 3386)
  AUTHORS   Rein HL and Bernstein KA.
  TITLE     Finding significance: New perspectives in variant classification of
            the RAD51 regulators, BRCA2 and beyond
  JOURNAL   DNA Repair (Amst) 130, 103563 (2023)
   PUBMED   37651978
  REMARK    GeneRIF: Finding significance: New perspectives in variant
            classification of the RAD51 regulators, BRCA2 and beyond. Review
            article
REFERENCE   2  (residues 1 to 3386)
  AUTHORS   Mohammed Ali SH, Abid Mohammed KI, Ali WM, Al-Fakhar SA, Al-Alwany
            SHM and Mousa JM.
  TITLE     Immunohistochemical Detection of the Expressed BRCA1 and BRCA2
            Proteins in Microenvironment of Malignant Breast Cancerous Tissues
            Infected with Human Mammary Tumor Virus
  JOURNAL   Asian Pac J Cancer Prev 24 (9), 3261-3267 (2023)
   PUBMED   37774080
  REMARK    GeneRIF: Immunohistochemical Detection of the Expressed BRCA1 and
            BRCA2 Proteins in Microenvironment of Malignant Breast Cancerous
            Tissues Infected with Human Mammary Tumor Virus. Publication Status:
            Online-Only
REFERENCE   3  (residues 1 to 3386)
  AUTHORS   Wilcox N, Dumont M, Gonzalez-Neira A, Carvalho S, Joly Beauparlant
            C, Crotti M, Luccarini C, Soucy P, Dubois S, Nunez-Torres R, Pita G,
            Gardner EJ, Dennis J, Alonso MR, Alvarez N, Baynes C,
            Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK,
            Castelao JE, Chang-Claude J, Cornelissen S, Dork T, Engel C,
            Gago-Dominguez M, Guenel P, Hadjisavvas A, Hahnen E, Hartman M,
            Herraez B, Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M,
            Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der
            Kolk LE, Wahlstrom C, Wang Q, Perry JRB, Benitez J, Schmidt MK,
            Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P,
            Easton DF and Simard J.
  CONSRTM   SGBCC Investigators
  TITLE     Exome sequencing identifies breast cancer susceptibility genes and
            defines the contribution of coding variants to breast cancer risk
  JOURNAL   Nat Genet 55 (9), 1435-1439 (2023)
   PUBMED   37592023
  REMARK    GeneRIF: Exome sequencing identifies breast cancer susceptibility
            genes and defines the contribution of coding variants to breast
            cancer risk. Erratum:[Nat Genet. 2023 Sep 26;:. PMID: 37752376]
REFERENCE   4  (residues 1 to 3386)
  AUTHORS   Setton J, Hadi K, Choo ZN, Kuchin KS, Tian H, Da Cruz Paula A,
            Rosiene J, Selenica P, Behr J, Yao X, Deshpande A, Sigouros M,
            Manohar J, Nauseef JT, Mosquera JM, Elemento O, Weigelt B, Riaz N,
            Reis-Filho JS, Powell SN and Imielinski M.
  TITLE     Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers
  JOURNAL   Nature 621 (7977), 129-137 (2023)
   PUBMED   37587346
  REMARK    GeneRIF: Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers.
REFERENCE   5  (residues 1 to 3386)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach
            R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat Genet 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (residues 1 to 3386)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc Natl Acad Sci U S A 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (residues 1 to 3386)
  AUTHORS   Mehta,P.A. and Ebens,C.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301575
REFERENCE   8  (residues 1 to 3386)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   9  (residues 1 to 3386)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301425
REFERENCE   10  (residues 1 to 3386)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: SRR14038191.2492720.1,
            SRR14038193.3672576.1 [ECO:0000332]
            RNAseq introns :: single sample supports all introns SAMEA1965299,
            SAMEA2142853 [ECO:0000348]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9 and AL137247.14.
            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The largest exon in both genes is exon
            11, which harbors the most important and frequent mutations in
            breast cancer patients. The BRCA2 gene was found on chromosome
            13q12.3 in human. The BRCA2 protein contains several copies of a 70
            aa motif called the BRC motif, and these motifs mediate binding to
            the RAD51 recombinase which functions in DNA repair. BRCA2 is
            considered a tumor suppressor gene, as tumors with BRCA2 mutations
            generally exhibit loss of heterozygosity (LOH) of the wild-type
            allele. [provided by RefSeq, May 2020].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..3386
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     Protein         1..3386
                     /product="breast cancer type 2 susceptibility protein
                     isoform 3"
                     /note="BRCA1/BRCA2-containing complex, subunit 2; breast
                     cancer type 2 susceptibility protein; DNA repair-associated
                     BRCA2; breast cancer 2 tumor suppressor; breast and ovarian
                     cancer susceptibility gene, early onset; Fanconi anemia
                     group D1 protein; breast and ovarian cancer susceptibility
                     protein 2; breast cancer 2, early onset; mutant BRCA2;
                     mutant DNA repair-associated protein 2"
                     /calculated_mol_wt="380461"
     Region          1..40
                     /region_name="Interaction with PALB2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          37..68
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            70
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          358..381
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            445
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            492
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          639..1000
                     /region_name="Interaction with NPM1.
                     /evidence=ECO:0000269|PubMed:21084279"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            755
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:17525332; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1002..1036
                     /region_name="BRCA2 1"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1003..2082
                     /region_name="Interaction with RAD51.
                     /evidence=ECO:0000250|UniProtKB:P97929"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1005..1033
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1216..1243
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1338..1781
                     /region_name="Interaction with POLH.
                     /evidence=ECO:0000269|PubMed:24485656"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1410..1595
                     /region_name="Required for stimulation of POLH DNA
                     polymerization activity"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1424..1452
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1522..1548
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1667..1695
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            1970
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1974..2002
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2035
                     /site_type="phosphorylation"
                     /note="Phosphothreonine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2051..2085
                     /region_name="BRCA2 8"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2055..2082
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2095
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2318..2513
                     /region_name="Interaction with FANCD2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2398..2418
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2449..2800
                     /region_name="Interaction with SEM1.
                     /evidence=ECO:0000269|PubMed:10373512,
                     ECO:0000269|PubMed:16205630"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2449..2635
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:430446"
     Region          2638..2764
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:430410"
     Region          2650..2666
                     /region_name="Nuclear export signal, masked by interaction
                     with SEM1. /evidence=ECO:0000269|PubMed:24013206"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            order(2658..2660,2686..2689,2691,2697..2699,2701,2717,
                     2725..2727,2743..2745)
                     /site_type="active"
                     /note="generic binding surface I [active]"
                     /db_xref="CDD:239939"
     Site            order(2693,2704,2707,2712,2715,2718,2750..2753,2755..2756,
                     2759..2760)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239939"
     Region          2772..3022
                     /region_name="BRCA2DBD_OB2"
                     /note="A subfamily of OB folds corresponding to the second
                     OB fold (OB2) of the 800-amino acid C-terminal ssDNA
                     binding domain (DBD) of BRCA2 (breast cancer susceptibility
                     gene 2) protein, called BRCA2DBD. BRCA2 participates in
                     homologous recombination-mediated...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(2776..2777,2779..2782,2784)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239940"
     Site            order(2794..2795,2797,2809,2814,2941,3018,3020..3022)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Site            order(2809,2939,2956,2958..2959,2994,2996)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239940"
     Region          3020..3154
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:430411"
     Site            order(3041,3087,3089,3091,3115)
                     /site_type="active"
                     /note="generic binding surface II [active]"
                     /db_xref="CDD:239941"
     Site            order(3054..3056,3096,3107,3109..3110)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     Site            3259
                     /site_type="phosphorylation"
                     /note="Phosphoserine, by CDK1 and CDK2.
                     /evidence=ECO:0000269|PubMed:15800615; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3287
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3355
                     /site_type="phosphorylation"
                     /note="Phosphothreonine, by CHEK1 and CHEK2.
                     /evidence=ECO:0000269|PubMed:18317453; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          3361..3386
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     CDS             1..3386
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /coded_by="NM_001406719.1:200..10360"
                     /note="isoform 3 is encoded by transcript variant 3"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
ORIGIN
        1 mpigskerpt ffeifktrcn kadlgpisln wfeelsseap pynsepaees ehknnnyepn
       61 lfktpqrkps ynqlastpii fkeqgltlpl yqspvkeldk fkldlgrnvp nsrhkslrtv
      121 ktkmdqaddv scpllnscls espvvlqcth vtpqrdksvv cgslfhtpkf vkgrqtpkhi
      181 seslgaevdp dmswssslat pptlsstvli vrneeasetv fphdttanvk syfsnhdesl
      241 kkndrfiasv tdsentnqre aashgfgkts gnsfkvnsck dhigksmpnv ledevyetvv
      301 dtseedsfsl cfskcrtknl qkvrtsktrk kifheanade ceksknqvke kysfvsevep
      361 ndtdpldsnv anqkpfesgs dkiskevvps lacewsqltl sglngaqmek ipllhisscd
      421 qnisekdlld tenkrkkdfl tsenslpris slpksekpln eetvvnkrde eqhleshtdc
      481 ilavkqaisg tspvassfqg ikksifrire spketfnasf sghmtdpnfk keteasesgl
      541 eihtvcsqke dslcpnlidn gswpatttqn svalknagli stlkkktnkf iyaihdetsy
      601 kgkkipkdqk selincsaqf eanafeaplt fanadsgllh ssvkrscsqn dseeptlslt
      661 ssfgtilrkc srnetcsnnt visqdldyke akcnkeklql fitpeadsls clqegqcend
      721 pkskkvsdik eevlaaachp vqhskveysd tdfqsqksll ydhenastli ltptskdvls
      781 nlvmisrgke sykmsdklkg nnyesdvelt knipmeknqd vcalnenykn vellppekym
      841 rvaspsrkvq fnqntnlrvi qknqeettsi skitvnpdse elfsdnennf vfqvanernn
      901 lalgntkelh etdltcvnep ifknstmvly gdtgdkqatq vsikkdlvyv laeenknsvk
      961 qhikmtlgqd lksdislnid kipeknndym nkwagllgpi snhsfggsfr tasnkeikls
     1021 ehnikkskmf fkdieeqypt slacveivnt laldnqkkls kpqsintvsa hlqssvvvsd
     1081 cknshitpqm lfskqdfnsn hnltpsqkae itelstilee sgsqfeftqf rkpsyilqks
     1141 tfevpenqmt ilkttseecr dadlhvimna psigqvdssk qfegtveikr kfagllkndc
     1201 nksasgyltd enevgfrgfy sahgtklnvs tealqkavkl fsdienisee tsaevhpisl
     1261 ssskchdsvv smfkienhnd ktvseknnkc qlilqnniem ttgtfveeit enykrntene
     1321 dnkytaasrn shnlefdgsd sskndtvcih kdetdllftd qhniclklsg qfmkegntqi
     1381 kedlsdltfl evakaqeach gntsnkeqlt atkteqnikd fetsdtffqt asgknisvak
     1441 esfnkivnff dqkpeelhnf slnselhsdi rknkmdilsy eetdivkhki lkesvpvgtg
     1501 nqlvtfqgqp erdekikept llgfhtasgk kvkiakesld kvknlfdeke qgtseitsfs
     1561 hqwaktlkyr eackdlelac etieitaapk ckemqnslnn dknlvsietv vppkllsdnl
     1621 crqtenlkts ksiflkvkvh enveketaks patcytnqsp ysviensala fytscsrkts
     1681 vsqtslleak kwlregifdg qperintady vgnylyenns nstiaendkn hlsekqdtyl
     1741 snssmsnsys yhsdevynds gylsknklds giepvlknve dqkntsfskv isnvkdanay
     1801 pqtvnedicv eelvtssspc knknaaikls isnsnnfevg ppafriasgk ivcvshetik
     1861 kvkdiftdsf skvikennen kskicqtkim agcyealdds edilhnsldn decsthshkv
     1921 fadiqseeil qhnqnmsgle kvskispcdv sletsdickc sigklhksvs santcgifst
     1981 asgksvqvsd aslqnarqvf seiedstkqv fskvlfksne hsdqltreen tairtpehli
     2041 sqkgfsynvv nssafsgfst asgkqvsile sslhkvkgvl eefdlirteh slhysptsrq
     2101 nvskilprvd krnpehcvns emektcskef klsnnlnveg gssennhsik vspylsqfqq
     2161 dkqqlvlgtk vslvenihvl gkeqaspknv kmeigktetf sdvpvktnie vcstyskdse
     2221 nyfeteavei akafmeddel tdsklpshat hslftcpene emvlsnsrig krrgeplilv
     2281 gtikdrrlfm hhvslepitc vpfrttkerq eiqnpnftap gqeflskshl yehltlekss
     2341 snlavsghpf yqvsatrnek mrhlittgrp tkvfvppfkt kshfhrveqc vrninleenr
     2401 qkqnidghgs ddsknkindn eihqfnknns nqavavtftk ceeepldlit slqnardiqd
     2461 mrikkkqrqr vfpqpgslyl aktstlpris lkaavggqvp sacshkqlyt ygvskhciki
     2521 nsknaesfqf htedyfgkes lwtgkgiqla dggwlipsnd gkagkeefyr alcdtpgvdp
     2581 klisriwvyn hyrwiiwkla amecafpkef anrclsperv llqlkyrydt eidrsrrsai
     2641 kkimerddta aktlvlcvsd iislsanise tssnktssad tqkvaiielt dgwyavkaql
     2701 dppllavlkn grltvgqkii lhgaelvgsp dactpleape slmlkisans trparwytkl
     2761 gffpdprpfp lplsslfsdg gnvgcvdvii qraypiqwme ktssglyifr nereeekeaa
     2821 kyveaqqkrl ealftkiqee feeheenttk pylpsraltr qqvralqdga elyeavknaa
     2881 dpaylegyfs eeqlralnnh rqmlndkkqa qiqleirkam esaeqkeqgl srdvttvwkl
     2941 rivsyskkek dsvilsiwrp ssdlysllte gkryriyhla tskskskser aniqlaatkk
     3001 tqyqqlpvsd eilfqiyqpr eplhfskfld pdfqpscsev dligfvvsvv kktglapfvy
     3061 lsdecynlla ikfwidlned iikphmliaa snlqwrpesk sglltlfagd fsvfsaspke
     3121 ghfqetfnkm kntvenidil cneaenklmh ilhandpkws tptkdctsgp ytaqiipgtg
     3181 nkllmsspnc eiyyqsplsl cmakrksvst pvsaqmtsks ckgekeiddq knckkrrald
     3241 flsrlplppp vspictfvsp aaqkafqppr scgtkyetpi kkkelnspqm tpfkkfneis
     3301 llesnsiade elalintqal lsgstgekqf isvsestrta ptssedylrl krrcttslik
     3361 eqessqaste eceknkqdti ttkkyi
//
LOCUS       NP_000050               3418 aa            linear   PRI 22-OCT-2023
DEFINITION  breast cancer type 2 susceptibility protein isoform 1 [Homo
            sapiens].
ACCESSION   NP_000050
VERSION     NP_000050.3
KEYWORDS    RefSeq; MANE Select.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    REFSEQ: accession NM_000059.4
REFERENCE   1  (residues 1 to 3418)
  AUTHORS   Rein HL and Bernstein KA.
  TITLE     Finding significance: New perspectives in variant classification of
            the RAD51 regulators, BRCA2 and beyond
  JOURNAL   DNA Repair (Amst) 130, 103563 (2023)
   PUBMED   37651978
  REMARK    GeneRIF: Finding significance: New perspectives in variant
            classification of the RAD51 regulators, BRCA2 and beyond. Review
            article
REFERENCE   2  (residues 1 to 3418)
  AUTHORS   Mohammed Ali SH, Abid Mohammed KI, Ali WM, Al-Fakhar SA, Al-Alwany
            SHM and Mousa JM.
  TITLE     Immunohistochemical Detection of the Expressed BRCA1 and BRCA2
            Proteins in Microenvironment of Malignant Breast Cancerous Tissues
            Infected with Human Mammary Tumor Virus
  JOURNAL   Asian Pac J Cancer Prev 24 (9), 3261-3267 (2023)
   PUBMED   37774080
  REMARK    GeneRIF: Immunohistochemical Detection of the Expressed BRCA1 and
            BRCA2 Proteins in Microenvironment of Malignant Breast Cancerous
            Tissues Infected with Human Mammary Tumor Virus. Publication Status:
            Online-Only
REFERENCE   3  (residues 1 to 3418)
  AUTHORS   Wilcox N, Dumont M, Gonzalez-Neira A, Carvalho S, Joly Beauparlant
            C, Crotti M, Luccarini C, Soucy P, Dubois S, Nunez-Torres R, Pita G,
            Gardner EJ, Dennis J, Alonso MR, Alvarez N, Baynes C,
            Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK,
            Castelao JE, Chang-Claude J, Cornelissen S, Dork T, Engel C,
            Gago-Dominguez M, Guenel P, Hadjisavvas A, Hahnen E, Hartman M,
            Herraez B, Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M,
            Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der
            Kolk LE, Wahlstrom C, Wang Q, Perry JRB, Benitez J, Schmidt MK,
            Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P,
            Easton DF and Simard J.
  CONSRTM   SGBCC Investigators
  TITLE     Exome sequencing identifies breast cancer susceptibility genes and
            defines the contribution of coding variants to breast cancer risk
  JOURNAL   Nat Genet 55 (9), 1435-1439 (2023)
   PUBMED   37592023
  REMARK    GeneRIF: Exome sequencing identifies breast cancer susceptibility
            genes and defines the contribution of coding variants to breast
            cancer risk. Erratum:[Nat Genet. 2023 Sep 26;:. PMID: 37752376]
REFERENCE   4  (residues 1 to 3418)
  AUTHORS   Setton J, Hadi K, Choo ZN, Kuchin KS, Tian H, Da Cruz Paula A,
            Rosiene J, Selenica P, Behr J, Yao X, Deshpande A, Sigouros M,
            Manohar J, Nauseef JT, Mosquera JM, Elemento O, Weigelt B, Riaz N,
            Reis-Filho JS, Powell SN and Imielinski M.
  TITLE     Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers
  JOURNAL   Nature 621 (7977), 129-137 (2023)
   PUBMED   37587346
  REMARK    GeneRIF: Long-molecule scars of backup DNA repair in BRCA1- and
            BRCA2-deficient cancers.
REFERENCE   5  (residues 1 to 3418)
  AUTHORS   Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach
            R, Naylor S, Joenje H and Grompe M.
  TITLE     Microcell mediated chromosome transfer maps the Fanconi anaemia
            group D gene to chromosome 3p
  JOURNAL   Nat Genet 11 (3), 341-343 (1995)
   PUBMED   7581463
REFERENCE   6  (residues 1 to 3418)
  AUTHORS   Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E,
            Weinstein CL, Bittner M, Meltzer PS, Trent JM et al.
  TITLE     Identification by representational difference analysis of a
            homozygous deletion in pancreatic carcinoma that lies within the
            BRCA2 region
  JOURNAL   Proc Natl Acad Sci U S A 92 (13), 5950-5954 (1995)
   PUBMED   7597059
REFERENCE   7  (residues 1 to 3418)
  AUTHORS   Mehta,P.A. and Ebens,C.
  TITLE     Fanconi Anemia
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301575
REFERENCE   8  (residues 1 to 3418)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   9  (residues 1 to 3418)
  AUTHORS   Petrucelli,N., Daly,M.B. and Pal,T.
  TITLE     BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH,
            Gripp KW and Amemiya A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301425
REFERENCE   10  (residues 1 to 3418)
  AUTHORS   Watson,C.G.
  TITLE     The life of a resolution--how ADA policy is made
  JOURNAL   J Conf Workshop, 14-23 (1975)
   PUBMED   1072445
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: SRR14038193.3812502.1 [ECO:0000332]
            RNAseq introns :: single sample supports all introns SAMEA1965299,
            SAMEA1968968 [ECO:0000348]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            MANE Ensembl match          :: ENST00000380152.8/ ENSP00000369497.3
            RefSeq Select criteria :: based on manual assertion, conservation,
            expression, longest protein
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL445212.9 and AL137247.14.
            On Feb 27, 2020 this sequence version replaced NP_000050.2.
            Summary: Inherited mutations in BRCA1 and this gene, BRCA2, confer
            increased lifetime risk of developing breast or ovarian cancer.
            Both BRCA1 and BRCA2 are involved in maintenance of genome
            stability, specifically the homologous recombination pathway for
            double-strand DNA repair. The largest exon in both genes is exon
            11, which harbors the most important and frequent mutations in
            breast cancer patients. The BRCA2 gene was found on chromosome
            13q12.3 in human. The BRCA2 protein contains several copies of a 70
            aa motif called the BRC motif, and these motifs mediate binding to
            the RAD51 recombinase which functions in DNA repair. BRCA2 is
            considered a tumor suppressor gene, as tumors with BRCA2 mutations
            generally exhibit loss of heterozygosity (LOH) of the wild-type
            allele. [provided by RefSeq, May 2020].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..3418
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q13.1"
     Protein         1..3418
                     /product="breast cancer type 2 susceptibility protein
                     isoform 1"
                     /note="BRCA1/BRCA2-containing complex, subunit 2; breast
                     cancer type 2 susceptibility protein; DNA repair-associated
                     BRCA2; breast cancer 2 tumor suppressor; breast and ovarian
                     cancer susceptibility gene, early onset; Fanconi anemia
                     group D1 protein; breast and ovarian cancer susceptibility
                     protein 2; breast cancer 2, early onset; mutant BRCA2;
                     mutant DNA repair-associated protein 2"
                     /calculated_mol_wt="384101"
     Region          1..40
                     /region_name="Interaction with PALB2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          37..68
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            70
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          358..381
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            445
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            492
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          639..1000
                     /region_name="Interaction with NPM1.
                     /evidence=ECO:0000269|PubMed:21084279"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            755
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:17525332; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1002..1036
                     /region_name="BRCA2 1"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1003..2082
                     /region_name="Interaction with RAD51.
                     /evidence=ECO:0000250|UniProtKB:P97929"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1005..1033
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1216..1243
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1338..1781
                     /region_name="Interaction with POLH.
                     /evidence=ECO:0000269|PubMed:24485656"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1410..1595
                     /region_name="Required for stimulation of POLH DNA
                     polymerization activity"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          1424..1452
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1522..1548
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Region          1667..1695
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            1970
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          1974..2002
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2035
                     /site_type="phosphorylation"
                     /note="Phosphothreonine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2051..2085
                     /region_name="BRCA2 8"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2055..2082
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:425790"
     Site            2095
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          2270..2337
                     /region_name="Interaction with HSF2BP.
                     /evidence=ECO:0000269|PubMed:31242413"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2350..2545
                     /region_name="Interaction with FANCD2"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2430..2450
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2481..2832
                     /region_name="Interaction with SEM1.
                     /evidence=ECO:0000269|PubMed:10373512,
                     ECO:0000269|PubMed:16205630"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Region          2481..2667
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:430446"
     Region          2670..2796
                     /region_name="BRCA-2_OB1"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 1; pfam09103"
                     /db_xref="CDD:430410"
     Region          2682..2698
                     /region_name="Nuclear export signal, masked by interaction
                     with SEM1. /evidence=ECO:0000269|PubMed:24013206"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     Site            order(2690..2692,2718..2721,2723,2729..2731,2733,2749,
                     2757..2759,2775..2777)
                     /site_type="active"
                     /note="generic binding surface I [active]"
                     /db_xref="CDD:239939"
     Site            order(2725,2736,2739,2744,2747,2750,2782..2785,2787..2788,
                     2791..2792)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239939"
     Region          2804..3054
                     /region_name="BRCA2DBD_OB2"
                     /note="A subfamily of OB folds corresponding to the second
                     OB fold (OB2) of the 800-amino acid C-terminal ssDNA
                     binding domain (DBD) of BRCA2 (breast cancer susceptibility
                     gene 2) protein, called BRCA2DBD. BRCA2 participates in
                     homologous recombination-mediated...; cd04494"
                     /db_xref="CDD:239940"
     Site            order(2808..2809,2811..2814,2816)
                     /site_type="active"
                     /note="binding surface II [active]"
                     /db_xref="CDD:239940"
     Site            order(2826..2827,2829,2841,2846,2973,3050,3052..3054)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:239940"
     Site            order(2841,2971,2988,2990..2991,3026,3028)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239940"
     Region          3052..3186
                     /region_name="BRCA-2_OB3"
                     /note="BRCA2, oligonucleotide/oligosaccharide-binding,
                     domain 3; pfam09104"
                     /db_xref="CDD:430411"
     Site            order(3073,3119,3121,3123,3147)
                     /site_type="active"
                     /note="generic binding surface II [active]"
                     /db_xref="CDD:239941"
     Site            order(3086..3088,3128,3139,3141..3142)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:239941"
     Site            3291
                     /site_type="phosphorylation"
                     /note="Phosphoserine, by CDK1 and CDK2.
                     /evidence=ECO:0000269|PubMed:15800615; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3319
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:23186163; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Site            3387
                     /site_type="phosphorylation"
                     /note="Phosphothreonine, by CHEK1 and CHEK2.
                     /evidence=ECO:0000269|PubMed:18317453; propagated from
                     UniProtKB/Swiss-Prot (P51587.4)"
     Region          3393..3418
                     /region_name="Disordered.
                     /evidence=ECO:0000256|SAM:MobiDB-lite"
                     /note="propagated from UniProtKB/Swiss-Prot (P51587.4)"
     CDS             1..3418
                     /gene="BRCA2"
                     /gene_synonym="BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD;
                     FANCD1; GLM3; PNCA2; XRCC11"
                     /coded_by="NM_000059.4:200..10456"
                     /note="isoform 1 is encoded by transcript variant 1"
                     /db_xref="CCDS:CCDS9344.1"
                     /db_xref="GeneID:675"
                     /db_xref="HGNC:HGNC:1101"
                     /db_xref="MIM:600185"
ORIGIN
        1 mpigskerpt ffeifktrcn kadlgpisln wfeelsseap pynsepaees ehknnnyepn
       61 lfktpqrkps ynqlastpii fkeqgltlpl yqspvkeldk fkldlgrnvp nsrhkslrtv
      121 ktkmdqaddv scpllnscls espvvlqcth vtpqrdksvv cgslfhtpkf vkgrqtpkhi
      181 seslgaevdp dmswssslat pptlsstvli vrneeasetv fphdttanvk syfsnhdesl
      241 kkndrfiasv tdsentnqre aashgfgkts gnsfkvnsck dhigksmpnv ledevyetvv
      301 dtseedsfsl cfskcrtknl qkvrtsktrk kifheanade ceksknqvke kysfvsevep
      361 ndtdpldsnv anqkpfesgs dkiskevvps lacewsqltl sglngaqmek ipllhisscd
      421 qnisekdlld tenkrkkdfl tsenslpris slpksekpln eetvvnkrde eqhleshtdc
      481 ilavkqaisg tspvassfqg ikksifrire spketfnasf sghmtdpnfk keteasesgl
      541 eihtvcsqke dslcpnlidn gswpatttqn svalknagli stlkkktnkf iyaihdetsy
      601 kgkkipkdqk selincsaqf eanafeaplt fanadsgllh ssvkrscsqn dseeptlslt
      661 ssfgtilrkc srnetcsnnt visqdldyke akcnkeklql fitpeadsls clqegqcend
      721 pkskkvsdik eevlaaachp vqhskveysd tdfqsqksll ydhenastli ltptskdvls
      781 nlvmisrgke sykmsdklkg nnyesdvelt knipmeknqd vcalnenykn vellppekym
      841 rvaspsrkvq fnqntnlrvi qknqeettsi skitvnpdse elfsdnennf vfqvanernn
      901 lalgntkelh etdltcvnep ifknstmvly gdtgdkqatq vsikkdlvyv laeenknsvk
      961 qhikmtlgqd lksdislnid kipeknndym nkwagllgpi snhsfggsfr tasnkeikls
     1021 ehnikkskmf fkdieeqypt slacveivnt laldnqkkls kpqsintvsa hlqssvvvsd
     1081 cknshitpqm lfskqdfnsn hnltpsqkae itelstilee sgsqfeftqf rkpsyilqks
     1141 tfevpenqmt ilkttseecr dadlhvimna psigqvdssk qfegtveikr kfagllkndc
     1201 nksasgyltd enevgfrgfy sahgtklnvs tealqkavkl fsdienisee tsaevhpisl
     1261 ssskchdsvv smfkienhnd ktvseknnkc qlilqnniem ttgtfveeit enykrntene
     1321 dnkytaasrn shnlefdgsd sskndtvcih kdetdllftd qhniclklsg qfmkegntqi
     1381 kedlsdltfl evakaqeach gntsnkeqlt atkteqnikd fetsdtffqt asgknisvak
     1441 esfnkivnff dqkpeelhnf slnselhsdi rknkmdilsy eetdivkhki lkesvpvgtg
     1501 nqlvtfqgqp erdekikept llgfhtasgk kvkiakesld kvknlfdeke qgtseitsfs
     1561 hqwaktlkyr eackdlelac etieitaapk ckemqnslnn dknlvsietv vppkllsdnl
     1621 crqtenlkts ksiflkvkvh enveketaks patcytnqsp ysviensala fytscsrkts
     1681 vsqtslleak kwlregifdg qperintady vgnylyenns nstiaendkn hlsekqdtyl
     1741 snssmsnsys yhsdevynds gylsknklds giepvlknve dqkntsfskv isnvkdanay
     1801 pqtvnedicv eelvtssspc knknaaikls isnsnnfevg ppafriasgk ivcvshetik
     1861 kvkdiftdsf skvikennen kskicqtkim agcyealdds edilhnsldn decsthshkv
     1921 fadiqseeil qhnqnmsgle kvskispcdv sletsdickc sigklhksvs santcgifst
     1981 asgksvqvsd aslqnarqvf seiedstkqv fskvlfksne hsdqltreen tairtpehli
     2041 sqkgfsynvv nssafsgfst asgkqvsile sslhkvkgvl eefdlirteh slhysptsrq
     2101 nvskilprvd krnpehcvns emektcskef klsnnlnveg gssennhsik vspylsqfqq
     2161 dkqqlvlgtk vslvenihvl gkeqaspknv kmeigktetf sdvpvktnie vcstyskdse
     2221 nyfeteavei akafmeddel tdsklpshat hslftcpene emvlsnsrig krrgeplilv
     2281 gepsikrnll nefdriienq ekslkaskst pdgtikdrrl fmhhvslepi tcvpfrttke
     2341 rqeiqnpnft apgqeflsks hlyehltlek sssnlavsgh pfyqvsatrn ekmrhlittg
     2401 rptkvfvppf ktkshfhrve qcvrninlee nrqkqnidgh gsddsknkin dneihqfnkn
     2461 nsnqavavtf tkceeepldl itslqnardi qdmrikkkqr qrvfpqpgsl ylaktstlpr
     2521 islkaavggq vpsacshkql ytygvskhci kinsknaesf qfhtedyfgk eslwtgkgiq
     2581 ladggwlips ndgkagkeef yralcdtpgv dpklisriwv ynhyrwiiwk laamecafpk
     2641 efanrclspe rvllqlkyry dteidrsrrs aikkimerdd taaktlvlcv sdiislsani
     2701 setssnktss adtqkvaiie ltdgwyavka qldppllavl kngrltvgqk iilhgaelvg
     2761 spdactplea peslmlkisa nstrparwyt klgffpdprp fplplsslfs dggnvgcvdv
     2821 iiqraypiqw mektssglyi frnereeeke aakyveaqqk rlealftkiq eefeeheent
     2881 tkpylpsral trqqvralqd gaelyeavkn aadpaylegy fseeqlraln nhrqmlndkk
     2941 qaqiqleirk amesaeqkeq glsrdvttvw klrivsyskk ekdsvilsiw rpssdlysll
     3001 tegkryriyh latsksksks eraniqlaat kktqyqqlpv sdeilfqiyq preplhfskf
     3061 ldpdfqpscs evdligfvvs vvkktglapf vylsdecynl laikfwidln ediikphmli
     3121 aasnlqwrpe sksglltlfa gdfsvfsasp keghfqetfn kmkntvenid ilcneaenkl
     3181 mhilhandpk wstptkdcts gpytaqiipg tgnkllmssp nceiyyqspl slcmakrksv
     3241 stpvsaqmts ksckgekeid dqknckkrra ldflsrlplp ppvspictfv spaaqkafqp
     3301 prscgtkyet pikkkelnsp qmtpfkkfne isllesnsia deelalintq allsgstgek
     3361 qfisvsestr taptssedyl rlkrrcttsl ikeqessqas teeceknkqd tittkkyi
//
